Morbid obesity Thromboembolism Pulmonary embolism Deep vein thrombosis venous thromboembolism prophylaxis bariatric surgery morbid obesity enoxaparin Anti-
Conditions
Interventions
enoxaparin 60 mg group subcutaneous injection 12 hours before surgery,enoxaparin 40 mg group subcutaneous injection 12 hours before surgery (Controlled group)
enoxaparin 60 mg group,enoxaparin 40 mg group
Sponsors
none
Eligibility
Sex/Gender
All
Age
15 Years to 60 Years
Inclusion criteria
Inclusion criteria: Patient at age between 15 years and 60 years, BMI equal or more than 32.5 kg/m2 with one of co-morbid diseases such as diabetes mellitus, cardiac disease, hypertension, Obstructive sleep apnea, weight bearing joint pain or the patients that have BMI equal or more than 37.5 kg/m2.
Exclusion criteria
Exclusion criteria: patient with VTE or prior using anticoagulant and the patients with the severe medical condition which cannot go on operation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The percentage of target level achievement in both groups 1 year Percentage of achievement target level | — |
Secondary
| Measure | Time frame |
|---|---|
| The mean anti-factor Xa levels in both groups 1 year mean as IU/ml | — |
Countries
Thailand
Contacts
Public ContactKritsada Kongsawat
Research affairs, Faculty of medicine, Chulalongkorn university
Outcome results
None listed